{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:16:51Z","timestamp":1776734211612,"version":"3.51.2"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Centers for Disease Control, Taiwan","award":["MOHW-107-CDC-C-114-000104"],"award-info":[{"award-number":["MOHW-107-CDC-C-114-000104"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The prevalence and incidence of latent tuberculosis infection (LTBI) in patients with kidney transplantation remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this prospective study, we enrolled kidney transplantation candidates (KTCs) and recipients (KTRs) from 2014 to 2018. We defined LTBI as a positive result of QuantiFERON-TB Gold In-tube (QFT). We analyzed the predictors for LTBI acquisition and followed up on QFT assay test for 2 years among those initially without LTBI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 425 patients enrolled, 305 (71.8%) patients belonged to the KTC group and 120 (28.2%) to the KTR group. The initial QFT showed positive results in 32 (10.5%) and 24 (20.0%) patients in the KTC and KTR groups, respectively (P = .009). The QFT response value in patients with LTBI was higher in the KTR group than in the KTC group (1.85 vs 1.06 IU\/mL, P = .046). Multivariate logistic regression showed that old age, absence of bacillus Calmette\u2013Gu\u00e9rin (BCG) scar, presence of donor-specific antibody, and KTR group were independent factors for positive LTBI. For participants with initial negative QFT, positive QFT conversion within a 2-year follow-up was higher after kidney transplantation (20%) than in KTCs (5.5%) (P = .034).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study is the first cohort to follow up LTBI status in patients with kidney transplantation and shows its higher prevalence and incidence in KTRs. It indicates that surveillance of LTBI after renal transplantation is important. In addition to status of kidney transplantation, old age, no BCG vaccination, and positive donor-specific antibody are also positive predictors for LTBI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz851","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T03:19:21Z","timestamp":1593573561000},"page":"914-923","source":"Crossref","is-referenced-by-count":21,"title":["Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control"],"prefix":"10.1093","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-5148","authenticated-orcid":false,"given":"Chin-Chung","family":"Shu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Kun","family":"Tsai","sequence":"additional","affiliation":[{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Department of Surgery, National Taiwan University Hospital, Taipei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Department of Surgery, National Taiwan University Hospital, Taipei"},{"name":"Center of Precision Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"2020081419072387500_CIT0001","volume-title":"Global Tuberculosis Report 2018","year":"2018"},{"key":"2020081419072387500_CIT0002","volume-title":"Group at risk: WHO report on the tuberculosis epidemic","author":"World Health Organization","year":"1996"},{"key":"2020081419072387500_CIT0003","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2014.11.020","article-title":"Tuberculosis elimination in the post Millennium Development Goals era","volume":"32","author":"Wejse","year":"2015","journal-title":"Int J Infect Dis"},{"key":"2020081419072387500_CIT0004","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"2020081419072387500_CIT0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.160.10.1513","article-title":"Benefits of screening for latent Mycobacterium tuberculosis infection","volume":"160","author":"Rose","year":"2000","journal-title":"Arch Intern Med"},{"key":"2020081419072387500_CIT0006","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2334-14-387","article-title":"The risk factors for tuberculosis in liver or kidney transplant recipients","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020081419072387500_CIT0007","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081419072387500_CIT0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3062.2009.00475.x","article-title":"Tuberculosis following solid organ transplantation","volume":"12","author":"Lopez de Castilla","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"2020081419072387500_CIT0009","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome: a French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2020081419072387500_CIT0010","doi-asserted-by":"crossref","first-page":"e12943","DOI":"10.1111\/tid.12943","article-title":"Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: a multicentric case-control study in a low-endemic area","volume":"20","author":"Gras","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2020081419072387500_CIT0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2019.01.049","article-title":"Latent tuberculosis infection and renal transplantation\u2014diagnosis and management","volume":"80S","author":"Krishnamoorthy","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2020081419072387500_CIT0012","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"2020081419072387500_CIT0013","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"2020081419072387500_CIT0014","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients: a TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081419072387500_CIT0015","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/TP.0b013e3182907073","article-title":"Contribution of interferon-gamma release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation","volume":"95","author":"Hadaya","year":"2013","journal-title":"Transplantation"},{"key":"2020081419072387500_CIT0016","volume-title":"Taiwan guidelines for TB diangosis and treatment","author":"Chiang","year":"2017","edition":"5"},{"key":"2020081419072387500_CIT0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2334-10-48","article-title":"Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study","volume":"10","author":"Shu","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2020081419072387500_CIT0018","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","article-title":"Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells","volume":"163","author":"Lalvani","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081419072387500_CIT0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2020081419072387500_CIT0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.5588\/ijtld.11.0017","article-title":"Indeterminate QuantiFERON\u00ae-TB Gold results in a public health clinic setting","volume":"15","author":"Banach","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020081419072387500_CIT0021","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jfma.2016.07.007","article-title":"Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants","volume":"115","author":"Lee","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"2020081419072387500_CIT0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jfma.2012.12.012","article-title":"B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis","volume":"114","author":"Tsai","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"2020081419072387500_CIT0023","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/thx.2005.056887","article-title":"Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas","volume":"61","author":"Wang","year":"2006","journal-title":"Thorax"},{"key":"2020081419072387500_CIT0024","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/tid.12436","article-title":"Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes","volume":"17","author":"Grim","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"2020081419072387500_CIT0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/TP.0000000000000133","article-title":"Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period","volume":"98","author":"Sidhu","year":"2014","journal-title":"Transplantation"},{"key":"2020081419072387500_CIT0026","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2012-07-445007","article-title":"Intravenous immunoglobulin (IVIg) inhibits CD8 cytotoxic T-cell activation","volume":"120","author":"Tr\u00e9panier","year":"2012","journal-title":"Blood"},{"key":"2020081419072387500_CIT0027","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.1301260","article-title":"Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production","volume":"192","author":"Tjon","year":"2014","journal-title":"J Immunol"},{"key":"2020081419072387500_CIT0028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jinf.2013.07.029","article-title":"Dynamic changes in positive interferon-gamma release assay in a dialysis population: an observational cohort study","volume":"67","author":"Shu","year":"2013","journal-title":"J Infect"},{"key":"2020081419072387500_CIT0029","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"2020081419072387500_CIT0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2020081419072387500_CIT0031","doi-asserted-by":"crossref","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"Esmail","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2020081419072387500_CIT0032","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2014-205376","article-title":"Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases","volume":"74","author":"Hatzara","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020081419072387500_CIT0033","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/ecco-jcc\/jjy104","article-title":"Serial tuberculin skin tests improve the detection of latent tuberculosis infection in patients with inflammatory bowel disease","volume":"12","author":"Taxonera","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2020081419072387500_CIT0034","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10067-016-3462-z","article-title":"The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis","volume":"36","author":"Cuomo","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2020081419072387500_CIT0035","first-page":"214","article-title":"A 10-year experience of tuberculosis in solid-organ transplant recipients","volume":"13","author":"Ulubay","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"2020081419072387500_CIT0036","doi-asserted-by":"crossref","first-page":"e42592","DOI":"10.1371\/journal.pone.0042592","article-title":"Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis","volume":"7","author":"Shu","year":"2012","journal-title":"PLoS One"},{"key":"2020081419072387500_CIT0037","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying predictors of interferon-\u03b3 release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study","volume":"186","author":"Basu Roy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2020081419072387500_CIT0038","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/thoraxjnl-2012-202208","article-title":"Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates","volume":"68","author":"Chan","year":"2013","journal-title":"Thorax"},{"key":"2020081419072387500_CIT0039","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","author":"Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz851\/33462805\/ciz851.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/4\/914\/33653933\/ciz851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/4\/914\/33653933\/ciz851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T23:29:53Z","timestamp":1597447793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/4\/914\/5867272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,7,4]]},"published-print":{"date-parts":[[2020,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz851","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,15]]},"published":{"date-parts":[[2020,7,4]]}}}